Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream

DUBLIN, Jan. 24, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for the generic version of Estrace® Cream (estradiol va... Biopharmaceuticals, Generics, FDA Perrigo, Estrace, estradiol
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news